Literature DB >> 1649823

Different pathways of uptake and degradation of sphingomyelin by lymphoblastoid cells and the potential participation of the neutral sphingomyelinase.

T Levade1, S Gatt, A Maret, R Salvayre.   

Abstract

The metabolism of sphingomyelin (SPM) was investigated in Epstein-Barr virus-transformed lymphoid cell lines from normal individuals and from patients with Niemann-Pick disease Type A (deficient in the acid, lysosomal sphingomyelinase) and familial hypercholesterolemia (lacking the low density lipoprotein receptor). Cells were incubated with the following radioactive or fluorescent SPMs: [choline-methyl-14C] SPM, [oleoyl-3H]SPM, pyrene-propenoyl-SPM (P3:1-SPM), pyrene-butanoyl-SPM (P4-SPM), pyrene-dodecanoyl-SPM (P12-SPM), and pyrene-sulfonylamino-undecanoyl-SPM (PSA11-SPM). Several pathways of uptake and subsequent metabolism of SPM in the lymphoblastoid cells were identified. [choline-methyl-14C]SPM and the P12-analog, administered to the cells in the presence of lipoproteins, were taken up through the apoB/E receptor-dependent pathway of endocytosis and degraded solely by the lysosomal sphingomyelinase. Under similar conditions, the other sphingomyelins, i.e. [oleoyl-3H]SPM, P3:1-SPM, P4-SPM, and PSA11-SPM, were taken up by a low density lipoprotein receptor-independent pathway and degraded mostly by a nonlysosomal sphingomyelinase which also catalyzed their hydrolysis in Niemann-Pick cells. In the absence of serum, all sphingomyelins were taken up by an apoB/E receptor-independent pathway and hydrolyzed by a nonlysosomal sphingomyelinase. Indeed, in vitro assays demonstrated the presence, in lymphoblastoid cells, of the neutral magnesium-activated sphingomyelinase, which was also fully active in the Niemann-Pick cells. In conclusion, our observations are consistent with: (i) the existence in lymphoblastoid cells of several pathways for the uptake and subsequent utilization of SPM; (ii) a major role of lipoproteins for the metabolic routing of the SPM; and (iii) the effect of the structure of the fatty acyl residue of SPM on its possible association with lipoproteins and/or cell membranes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649823

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

Review 2.  Cholesterol regulation of rab-mediated sphingolipid endocytosis.

Authors:  Miwa Takahashi; Toshihide Kobayashi
Journal:  Glycoconj J       Date:  2008-10-08       Impact factor: 2.916

3.  Endocytic trafficking of sphingomyelin depends on its acyl chain length.

Authors:  Mirkka Koivusalo; Maurice Jansen; Pentti Somerharju; Elina Ikonen
Journal:  Mol Biol Cell       Date:  2007-10-17       Impact factor: 4.138

4.  Mutation in EGFP domain of LDL receptor-related protein 6 impairs cellular LDL clearance.

Authors:  Wenzhong Liu; Sheida Mani; Nicole R Davis; Nizal Sarrafzadegan; Paula B Kavathas; Arya Mani
Journal:  Circ Res       Date:  2008-10-23       Impact factor: 17.367

5.  Functional compartments of sulphatide metabolism in cultured living cells: evidence for the involvement of a novel sulphatide-degrading pathway.

Authors:  M C Tempesta; R Salvayre; T Levade
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

6.  Molecular modeling of human neutral sphingomyelinase provides insight into its molecular interactions.

Authors:  Angshumala Goswami; Panneer Selvam Suresh; Chinnasamy Thirunavukkarasu; Oliver H Weiergräber; Muthuvel Suresh Kumar
Journal:  Bioinformation       Date:  2011-08-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.